4
Changes in Ownership
KYNTRA BIO, INC. Filed Acc 0001209191-21-012546
Director sold 6,000 shares at an average $52.40 ($314,383)
- Director acquired 6,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Kurkijarvi Kalevi · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-02-17 | Exercise or conversion : show line 1 in the form | +6,000 | $28.65 | $171,900 | 39,100 | D |
| 2021-02-17 | Sale : show line 2 in the form | −5,156 | $52.31 | $269,710 | 33,944 | D |
| 2021-02-17 | Sale : show line 3 in the form | −844 | $52.93 | $44,673 | 33,100 | D |
| Open-market sales · 6,000 sh · avg $52.40 · $314,383 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2021-02-17 | Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) | −6,000 | $28.65 | 2027-06-07 | 6,000 | 6,000 | D |
Loading xslF345X03/doc4.xml…